February 12, 2014 | Israeli biomed startup Bio-Sep, which develops technology to magnetically separate rare blood cells, has announced the closing of its first round of financing, raising $5.3 million. The final $2 million investment was made by private investment fund BRM.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments